US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Skyward Specialty Insurance Group Inc (SKWD)
Skyward Specialty Insurance Group Inc (SKWD) ニュース

Skyward Specialty Insurance Group Inc (SKWD)

62.41

2.21

(3.67%)

終了 7月8日 5:00AM

62.41

0.00

( 0.00% )

プレマーケット: 8:43PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Skyward Specialty to Host Second Quarter 2026 Earnings Call Wednesday, August 5, 2026

HOUSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.TM (NASDAQ: SKWD) ("Skyward...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144/A - Report of proposed sale of securities: [Amend]

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Skyward Specialty Appoints Melissa Goto to Lead E&S Brokerage and Inland Marine Businesses

HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.®, a Skyward Group Company...

Form 144/A - Report of proposed sale of securities: [Amend]

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Truthsocial

Truthsocial 3分前

Keeping it real.. you lose...Vivos Inc. (ticker: RDGL) is the developer of PrecisionGel, a proprietary hydrogel polymer platform designed to deliver active pharmaceutical ingredients and therapeutic agents. Unlike its investigational cancer treatment RadioGel, which uses yttrium-90 for radiation, P

chereb19

chereb19 3分前

You can't even get the patient population right. The FDA authorization isn't for "patients with cancers that have spread beyond the thyroid gland." It is for a feasibility study in patients with non-resectable papillary thyroid carcinoma. Those are not synonymous, and inventing broader inclusion cri

Drugdoctor

Drugdoctor 4分前

$WNFT shell has-been-sold!!! New Owner-WOWSERS-NEWS!
George Sharp sold the shell to Jay Wright before George Sharp died,

Suddenly the stock is soaring - you may want to watch this one folks.

First - here is the acquisition NEWS -
Worldwide NFT, Inc. Annou

stockrafter

stockrafter 4分前

A lonely site, obviously due to a bunch of poor investors out there who can't comprehend what the incredible team at Acumen is developing.

Oh well, not much this lonely investor can do but keep on posting new facts and info till the BIG day......

This an interesting AI

PurpleCritter2001

PurpleCritter2001 6分前

Crypttolit

Crypttolit 7分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

Crypttolit

Crypttolit 8分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

Crypttolit

Crypttolit 8分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

Crypttolit

Crypttolit 8分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

ORCA

https://x.com/ericjackson/status/2070446740382097841

Crypttolit

Crypttolit 9分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

GNIS DD: basically i think the OTC is mostly sleeping on the fact that one of their low SS subpennies has been working w a $40 billion Miami real estate family - in the RWA tokenization space, that just had its first RWA tokenization stock via a SPAC go public on the NYSE July 2nd, 2026.

Crypttolit

Crypttolit 9分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

Crypttolit

Crypttolit 10分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

Real McCoy

Real McCoy 10分前

I suppose. It took some time and there were a lot of loose ends to tie up. But they got it done back in ‘18. Enron was even more complex with all those subsidiaries.

Crypttolit

Crypttolit 10分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

GR8 Dad

GR8 Dad 10分前

Well, at least he acknowledges it's a pump and dump.

I also agree with his trading method. You can make money off of the backs of these pump and dump criminals. And should do so in order to dampen the effect of there pump. (With this share structure, this could be pumped fairly high.

rheddle

rheddle 11分前

That's a big assumption right there.

Crypttolit

Crypttolit 11分前

Check out @Gotti777 message on Stocktwits http://stocktwits.com/Gotti777/message/658526267

bb8675309

bb8675309 12分前

Obamacare insurers ask for second-highest premiums increase in nearly a decade

Blarcamesine could help offset the cost in the CNS space. Imo

https://finance.yahoo.com/healthcare/articles/obamacare-insurers-ask-second-highest-090355603.html

Nelson2

Nelson2 12分前

Good skinny Thank you
GLTU

CA Market News

CA Market News 13分前

CanAlaska Announces Senior Management ChangeJuly 8, 2026 7:30 AM
NewsfileNathan Bridge Resigns as Vice-President E

US Market News

US Market News 13分前

MarineMax Expands Distribution Opportunities for Financing & Insurance Offerings Through Partnership with NextBoatJuly 8, 2026 8:00 AM
Business Wire MarineMax, Inc. (NYSE: HZO), the world's largest recreational boat and yacht retailer, marina operator and superyacht services co

Yes - kinda cool that in usual slow summer we have some great penny stock runners. The OTC was cleaned up - though painful in 2021 maybe in time for the better.

Skyward Specialty Insura...

Electric Power Dev

Airops Share Cls Lvl Pre...

Xtrackers MSCI AC World ...

Odyssey Resources

Societe Generale Effekten

RSE Archive (GM)

Ci Mosaic Balanced Growt...

Etfs Heating Oil Micro

Xtrackers India Governme...

FuelCell Energy

DJ US Financial Administ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。